Rockwell Automation Announces New Propack Data PMX MES Release for Life Sciences Companies
Newest version of Propack Data PMX MES validation-ready software provides on-demand manufacturing information to help improve productivity, compliance and speed-to-market.
MILWAUKEE – August 9, 2005 – Rockwell Automation announces the latest version of its leading Enterprise Production Management (EPM) software focused on the life sciences industry – Propack Data PMX MES 4.1. The new version supports cost-effective, risk-based manufacturing approaches through fast electronic batch record reviews, flexible and controlled operator work instructions, and on-demand views of production information from raw material receipt through product release.
"Today's life sciences companies are looking beyond blockbuster drugs and patent protection and into manufacturing operations for strategic advantages," said Robert Honor, life sciences vice president, Rockwell Automation. "With Propack Data PMX MES software, companies can optimize operations in line with the FDA's risk-based approach, making manufacturing capabilities a competitive advantage."
The newest version provides extended equipment and material flow capabilities to track and manage raw materials, work-in-process and final products. With browser-based clients and seamless integration to Rockwell Software RSBizWare Batch, Rockwell Software RSBizWare Historian and third party batch and historian systems, users can access comprehensive manufacturing information on-demand and fast-track electronic batch record reviews. Propack Data PMX MES also is validation-ready for rapid, compliant-ready implementations and overall lower total cost of ownership.
Propack Data PMX MES software is a key element in the completeRockwell Automation Enterprise Production Management (EPM) suite designed to help improve product quality and safety, increase efficiency and assist with regulatory com-pliance. The complete EPM suite provides extensive capabilities for manufacturing execution, clinical supply management, batch management, line performance and monitoring and complete automation across clinical, primary and secondary operations.
Rockwell Automation (NYSE: ROK), is a leading global provider of automation, power, control, and information solutions that help manufacturers achieve a competitive advantage in their businesses. Headquartered in Milwaukee, Wis., U.S.A., the company employs about 20,000 people serving customers in more than 80 countries.
For more information on Propack Data PMX MES, please contact theRockwell Automation Response Center, 10701 Hampshire Avenue South, Bloomington, Minn., 55438, 800.223.5354, Ext. 1783.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Phase III SELECT-GCA Trial Results Lead to FDA Approval of Rinvoq for Giant Cell Arteritis
April 30th 2025Rinvoq (upadacitinib) becomes the first oral JAK inhibitor approved by the FDA for the treatment of giant cell arteritis in adults, following robust data from the Phase III SELECT-GCA trial demonstrating its efficacy in achieving sustained remission and reducing glucocorticoid exposure.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
